Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lactobacillus Paracasei CNCM I-1572
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
May 27, 2022
Lead Product(s) : Lactobacillus Paracasei CNCM I-1572
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Beclomethasone Dipropionate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 05, 2021
Lead Product(s) : Beclomethasone Dipropionate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Domperidone
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 04, 2019
Lead Product(s) : Domperidone
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : L.Casei Dg
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : 1Med
Deal Size : Inapplicable
Deal Type : Inapplicable
L. Casei DG® in Patients With Irritable Bowel Syndrome.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
February 28, 2018
Lead Product(s) : L.Casei Dg
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : 1Med
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bifidobacterium
Therapeutic Area : Pediatrics
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Microorganism
Upfront Cash : Inapplicable
February 15, 2018
Lead Product(s) : Bifidobacterium
Therapeutic Area : Pediatrics
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bifidobacterium
Therapeutic Area : Pediatrics
Study Phase : Undisclosed
Recipient : German Diabetes Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of a Probiotic (Bifidobacterium in the Treatment of Infantile Colic (IC)
Details : Undisclosed
Product Name : Undisclosed
Product Type : Microorganism
Upfront Cash : Inapplicable
December 09, 2016
Lead Product(s) : Bifidobacterium
Therapeutic Area : Pediatrics
Highest Development Status : Undisclosed
Recipient : German Diabetes Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Casei DG
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
February 25, 2015
Lead Product(s) : Lactobacillus Casei DG
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Casei DG
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
March 04, 2014
Lead Product(s) : Lactobacillus Casei DG
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Mesalazine
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 04, 2014
Lead Product(s) : Mesalazine
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Mesalazine
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 10, 2010
Lead Product(s) : Mesalazine
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable